119 related articles for article (PubMed ID: 11489278)
1. Sensorimotor demyelinating neuropathy with IgM antibody against gangliosides GD1a, GT1b and GM3.
Mizutani K; Oka N; Kusunoki S; Kaji R; Mezaki T; Akiguchi I; Shibasaki H
J Neurol Sci; 2001 Jul; 188(1-2):9-11. PubMed ID: 11489278
[TBL] [Abstract][Full Text] [Related]
2. [Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves: apropos of 112 cases].
Caudie C; Vial C; Petiot P; Bancel J; Lombard C; Gonnaud PM
Ann Biol Clin (Paris); 2001; 59(5):567-77. PubMed ID: 11602387
[TBL] [Abstract][Full Text] [Related]
3. Bulbar involvement in patients with antiganglioside antibodies against NeuNAc(alpha2-3)Gal.
Rojas-Garcia R; Gallardo E; De Luna N; Juarez C; Martinez-Hernandez E; Carvajal A; Casasnovas C; Fages E; Davila-González P; Illa I
J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):623-8. PubMed ID: 19726412
[TBL] [Abstract][Full Text] [Related]
4. Serum anti-ganglioside IgM antibodies in soft tissue sarcoma: clinical prognostic implications.
Perez CA; Ravindranath MH; Soh D; Gonzales A; Ye W; Morton DL
Cancer J; 2002; 8(5):384-94. PubMed ID: 12416896
[TBL] [Abstract][Full Text] [Related]
5. IgM M-protein in a patient with sensory-dominant neuropathy binds preferentially to polysialogangliosides.
Obi T; Kusunoki S; Takatsu M; Mizoguchi K; Nishimura Y
Acta Neurol Scand; 1992 Aug; 86(2):215-8. PubMed ID: 1384262
[TBL] [Abstract][Full Text] [Related]
6. Glycosphingolipid antigens in cultured bovine brain microvascular endothelial cells: sulfoglucuronosyl paragloboside as a target of monoclonal IgM in demyelinative neuropathy [corrected].
Kanda T; Yoshino H; Ariga T; Yamawaki M; Yu RK
J Cell Biol; 1994 Jul; 126(1):235-46. PubMed ID: 8027181
[TBL] [Abstract][Full Text] [Related]
7. Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies.
Lopate G; Choksi R; Pestronk A
Muscle Nerve; 2002 Jun; 25(6):828-36. PubMed ID: 12115971
[TBL] [Abstract][Full Text] [Related]
8. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies.
Nobile-Orazio E; Giannotta C; Briani C
J Neuroimmunol; 2010 Feb; 219(1-2):119-22. PubMed ID: 20006388
[TBL] [Abstract][Full Text] [Related]
9. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides.
Schnaar RL; Fromholt SE; Gong Y; Vyas AA; Laroy W; Wayman DM; Heffer-Lauc M; Ito H; Ishida H; Kiso M; Griffin JW; Shiekh KA
Anal Biochem; 2002 Mar; 302(2):276-84. PubMed ID: 11878808
[TBL] [Abstract][Full Text] [Related]
11. Severe motor-dominant neuropathy with IgM M-protein binding to the NeuAcalpha2-3Galbeta- moiety.
Oga T; Kusunoki S; Fujimura H; Kuboki T; Yoshida T; Takai T
J Neurol Sci; 1998 Jan; 154(1):4-7. PubMed ID: 9543315
[TBL] [Abstract][Full Text] [Related]
12. Anti-GD1a ganglioside antibodies in peripheral motor syndromes.
Carpo M; Nobile-Orazio E; Meucci N; Gamba M; Barbieri S; Allaria S; Scarlato G
Ann Neurol; 1996 Apr; 39(4):539-43. PubMed ID: 8619533
[TBL] [Abstract][Full Text] [Related]
13. IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release.
Ortiz N; Rosa R; Gallardo E; Illa I; Tomas J; Aubry J; Sabater M; Santafé M
J Neuroimmunol; 2001 Sep; 119(1):114-23. PubMed ID: 11525808
[TBL] [Abstract][Full Text] [Related]
14. Clinical phenotype of patients with neuropathy associated with monoclonal gammopathy: a comparative study and a review of the literature.
Stork AC; van der Pol WL; Franssen H; Jacobs BC; Notermans NC
J Neurol; 2014 Jul; 261(7):1398-404. PubMed ID: 24781837
[TBL] [Abstract][Full Text] [Related]
15. Sensorimotor polyneuropathy associated with chronic lymphocytic leukemia, IgM antigangliosides antibody and human T-cell leukemia virus I infection.
Mitsui Y; Kusunoki S; Hiruma S; Akamatsu M; Kihara M; Hashimoto S; Takahashi M
Muscle Nerve; 1999 Oct; 22(10):1461-5. PubMed ID: 10487916
[TBL] [Abstract][Full Text] [Related]
16. Ataxic polyneuropathy and anti-Pr2 IgM kappa M proteinemia.
Arai M; Yoshino H; Kusano Y; Yazaki Y; Ohnishi Y; Miyatake T
J Neurol; 1992 Mar; 239(3):147-51. PubMed ID: 1573418
[TBL] [Abstract][Full Text] [Related]
17. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
[TBL] [Abstract][Full Text] [Related]
18. Motor neuropathy with activity of monoclonal IgM antibody to GD1a ganglioside.
Bollensen E; Schipper HI; Steck AJ
J Neurol; 1989 Sep; 236(6):353-5. PubMed ID: 2795103
[TBL] [Abstract][Full Text] [Related]
19. High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization.
Lunn MP; Johnson LA; Fromholt SE; Itonori S; Huang J; Vyas AA; Hildreth JE; Griffin JW; Schnaar RL; Sheikh KA
J Neurochem; 2000 Jul; 75(1):404-12. PubMed ID: 10854286
[TBL] [Abstract][Full Text] [Related]
20. Acute relapsing sensory neuropathy associated with IgM antibody against B-series gangliosides containing a GalNAc beta 1-4(Gal3-2 alpha NeuAc8-2 alpha NeuAc)beta 1 configuration.
Yuki N; Miyatani N; Sato S; Hirabayashi Y; Yamazaki M; Yoshimura N; Hayashi Y; Miyatake T
Neurology; 1992 Mar; 42(3 Pt 1):686-9. PubMed ID: 1549241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
